Results 101 to 110 of about 22,526 (176)

Helix pomatia mucin alleviates DSS-induced colitis in mice: Unraveling the cross talk between microbiota and intestinal chemokine

open access: yesHeliyon
Gut microbiota imbalance and alterations in the chemokine-chemokine receptor interactions are pivotal in the initiation and advancement of ulcerative colitis (UC).
Maha B. Salem   +5 more
doaj   +1 more source

The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer

open access: yesJournal of Obstetrics and Gynaecology
Background The expression and function of coexpression genes of M1 macrophage in cervical cancer have not been identified. And the CXCL9-expressing tumour-associated macrophage has been poorly reported in cervical cancer.Methods To clarify the regulatory
Wenxin Liao   +5 more
doaj   +1 more source

Chemokine-derived glycosaminoglycan binding peptides: a new strategy for the inhibition of inflammation [PDF]

open access: yes, 2018
Chemokines or chemotactic cytokines are proteins (8-14 kDa) which are known to play an important role in the migration of leukocytes and can be classified, based on their function, into homeostatic and inflammatory chemokines. Inflammatory chemokines are
Vanheule, Vincent
core  

Rapid biolayer interferometry measurements of urinary CXCL9 to detect cellular infiltrates noninvasively after kidney transplantation [PDF]

open access: yes
Introduction: measuring the chemokine CXCL9 in urine by enzyme-linked immunosorbent assay (ELISA) can diagnose acute cellular rejection (ACR) noninvasively after kidney transplantation, but the required 12- to 24-hour turnaround time is not ideal for ...
Gandolfini, Ilaria   +20 more
core  

Molecular basis of CXC chemokine receptor 3 ligand multispecificity. [PDF]

open access: yesSci Adv
Bouyssou A   +15 more
europepmc   +1 more source

Day-30 IL1RL1, CXCL9 and REG3α are prognostic for survival after mismatched unrelated donor transplantation. [PDF]

open access: yesBr J Haematol
Wang T   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy